Loading…
Gamma-irradiation of Streptococcus pneumoniae for the use as an immunogenic whole cell vaccine
Streptococcus pneumoniae is a major respiratory pathogen that causes millions of deaths worldwide. Although subunit vaccines formulated with the capsular polysaccharides or their protein conjugates are currently-available, low-cost vaccines with wide serotype coverage still remain to be developed, e...
Saved in:
Published in: | The journal of microbiology 2018, 56(8), , pp.579-585 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Streptococcus pneumoniae
is a major respiratory pathogen that causes millions of deaths worldwide. Although subunit vaccines formulated with the capsular polysaccharides or their protein conjugates are currently-available, low-cost vaccines with wide serotype coverage still remain to be developed, especially for developing countries. Recently, gamma- irradiation has been considered as an effective inactivation method to prepare
S. pneumoniae
vaccine candidate. In this study, we investigated the immunogenicity and protective immunity of gamma-irradiated
S. pneumoniae
(r-SP), by comparing with heat-inactivated
S. pneumoniae
(h-SP) and formalin-inactivated
S. pneumoniae
(f-SP), both of which were made by traditional inactivation methods. Intranasal immunization of C57BL/6 mice with r-SP in combination with cholera toxin as an adjuvant enhanced
S. pneumoniaespecific
antibodies on the airway mucosal surface and in sera more potently than that with h-SP or f-SP under the same conditions. In addition, sera from mice immunized with r-SP potently induced opsonophagocytic killing activity more effectively than those of h-SP or f-SP, implying that r-SP could induce protective antibodies. Above all, immunization with r-SP effectively protected mice against
S. pneumoniae
infection. Collectively, these results suggest that gamma- irradiation is an effective method for the development of a killed whole cell pneumococcal vaccine that elicits robust mucosal and systemic immune responses. |
---|---|
ISSN: | 1225-8873 1976-3794 |
DOI: | 10.1007/s12275-018-8347-1 |